Amro Sehly, Albert He, Abdul Rahman Ihdayhid, Christine Grey, Scott O'Connor, Gillian Green, Matthew Erickson, James M Rankin, P Gerry Fegan, Bu B Yeap, Girish Dwivedi, Nick S R Lan
AIM: Left atrial (LA) strain, a novel marker of LA function, reliably predicts diastolic dysfunction. SGLT2 inhibitors improve heart failure outcomes, but limited data exists regarding their use in the immediate aftermath of acute coronary syndrome (ACS). We studied the effect of empagliflozin on LA strain in patients with type 2 diabetes (T2D) and ACS. METHODS: Patients with ACS and T2D were identified and empagliflozin was initiated in eligible patients prior to discharge...
March 8, 2024: Acta Cardiologica